The agency takes action against websites that illegally sell unapproved medications.

The International Conference on Harmonization finalizes Q&A document on APIs.

NIH provides an interim corrective action plan to correct deficiencies found in its Clinical Center Pharmaceutical Development Section.

Biomax Informatics AG and Pierre Fabre announced that they have entered into a collaboration to create an integrated antibody sequence and knowledge database.

GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.

EXCiPACT announces that DQS awarded Grace GmbH an EXCiPACT Certificate for its Worms, Germany excipient-manufacturing site.

The agency streamlines risk and mitigation information.

EvaluatePharma's report shows upward trends in R&D and drug approvals.

Lonza’s planned facility will be used to develop and manufacture viral gene therapies and virally modified cell therapies

MFG Tray names ChemTech International as its first Master Pharmaceutical Distributor.

A new SGS Life Science Services laboratory outside Paris is designed for bio/pharmaceutical quality control testing.

Kythera announces that it entered into a definitive agreement to be acquired by Allergan for $2.1 billion.

Careful choice of wash-water parameters and attention to water quality and basket loading are important for optimal cleaning.

Experts at Eppendorf discuss common challenges in cell culture and share insights on possible solutions.

Stan Matthews, sales manager, processing division at MG America, spoke with Pharmaceutical Technology about trends and concerns in capsule production.

The University of Pennsylvania announces that it will collaborate with WuXi AppTech to research and develop gene vectors derived from recombinant viruses.

The Biotechnology Industry Organization announced a name change to the Biotechnology Innovation Organization, effective in early 2016.

Catalent’s Singapore facility is awarded GMP certification.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Bayer Healthcare, Bristol-Myers Squibb, Sucampo Pharmaceuticals, Takeda Pharmaceuticals, and Horizon Pharma representatives join PhRMA board.

West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.

At BIO 2015, CQDM and MaRS Innovation announced an investment in Encycle Therapeutics to research chemical properties needed to make peptide-like molecules orally bioavailable.

The agency creates initiative to stimulate pediatric drug development.

CPhI Worldwide announces five new categories for the 2015 CPhI Pharma Awards.

BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.

A new GMP facility in Massachusetts will produce enzymes and other reagents for in-vitro diagnostics.

With drug development trends shifting towards personalized medicines, new technologies are needed for the manufacture of these highly sensitive drug products.

An advisory panel deemed Amgen’s Repatha (evolocumab) to be safe overall.